The results generated in H1 2021 by MedApp S.A. are similar to the results the Company achieved for the whole of 2020. The interview with Krzysztof Mędrala, CEO of MedApp S.A.

26 August 2021

The results generated in H1 2021 by MedApp S.A. are similar to the results the Company achieved for the whole of 2020. The interview with Krzysztof Mędrala, CEO of MedApp S.A.

In connection with the publication of the Interim Report for Q2 2021 on September 12, 2021, we invite you to watch the interview with Krzysztof Mędrala, CEO of MedApp S.A. according to Company’s activities realized in the reporting period and the financial results achieved in H1 2021.

If you have any investor questions, feel free to send them to biuro@medapp.pl!

Read more See similar articles:

26 March 2024

March 22, 2024, Barcelona – MedApp begins collaboration with Renalyse on revolutionary medical device for chronic kidney disease diagnosis

On Friday, March 22, we participated in an exciting kick-off meeting for the RenaMed project in Barcelona, Spain, organized by our partners from Renalyse. The meeting was held in one of Barcelona’s most iconic locations, La Pedrera.

26 February 2024

MedApp at HIMSS24

We are very pleased to announce that MedApp SA will participate in one of the largest medical-technology fairs in the world – HIMSS24, which will be held March 11-15, 2024 in Orlando, Florida.

03 January 2024

MedApp Clinics expands range of services offered – 2023 summary.

In the past year, MedAppClinics has made significant strides in developing and expanding its range of services. A key element of the company’s strategy was the integration with five renowned medical facilities, which strengthened its competence and reach.